Evolving treatment strategies of brain metastases from breast cancer: current status and future direction
- PMID: 32636942
- PMCID: PMC7313341
- DOI: 10.1177/1758835920936117
Evolving treatment strategies of brain metastases from breast cancer: current status and future direction
Abstract
Remarkable progress in breast cancer treatment has improved patient survival, resulting in an increased incidence of brain metastasis (BM). Current treatment options for BM are limited and are generally used for palliative purposes. Historically, local treatment, consisting of radiotherapy and surgery, is the standard of care due to delivery limitations of systemic treatments through the blood-brain barrier. However, as novel biological mechanisms for tumors and BM have been discovered, several innovative systemic agents, such as small-molecular-targeted therapy and immunotherapy, have begun to change the treatment paradigm. In addition, efforts to maximize antitumor effects have been attempted using combination therapy, informed by tumor biology. In this comprehensive review, we will highlight various clinical trials investigating the treatment of BM in breast cancer patients, discuss presently available treatment options, and suggest potential directions of future therapeutic targets.
Keywords: brain metastasis; breast cancer; clinical trial; local treatment; systemic treatment.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Similar articles
-
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?Cancers (Basel). 2024 Jul 5;16(13):2466. doi: 10.3390/cancers16132466. Cancers (Basel). 2024. PMID: 39001528 Free PMC article. Review.
-
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?Curr Treat Options Oncol. 2022 Jul;23(7):980-1000. doi: 10.1007/s11864-022-00982-0. Epub 2022 Apr 28. Curr Treat Options Oncol. 2022. PMID: 35482170 Free PMC article. Review.
-
Biology of brain metastases and novel targeted therapies: time to translate the research.Biochim Biophys Acta. 2013 Jan;1835(1):61-75. doi: 10.1016/j.bbcan.2012.10.005. Epub 2012 Nov 7. Biochim Biophys Acta. 2013. PMID: 23142311 Review.
-
Breast cancer brain metastasis: molecular mechanisms and directions for treatment.Neuro Oncol. 2018 Oct 9;20(11):1439-1449. doi: 10.1093/neuonc/noy044. Neuro Oncol. 2018. PMID: 29566179 Free PMC article. Review.
-
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov.Radiat Oncol. 2023 Apr 4;18(1):62. doi: 10.1186/s13014-023-02243-2. Radiat Oncol. 2023. PMID: 37016421 Free PMC article.
Cited by
-
A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases.NPJ Breast Cancer. 2021 Sep 14;7(1):121. doi: 10.1038/s41523-021-00326-5. NPJ Breast Cancer. 2021. PMID: 34521857 Free PMC article. Review.
-
Advances in the Management of Central Nervous System Metastases from Breast Cancer.Int J Mol Sci. 2022 Oct 19;23(20):12525. doi: 10.3390/ijms232012525. Int J Mol Sci. 2022. PMID: 36293379 Free PMC article. Review.
-
Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases.Breast Cancer (Dove Med Press). 2023 Nov 17;15:841-853. doi: 10.2147/BCTT.S440427. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 38020051 Free PMC article.
-
Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases.Ann Med. 2022 Dec;54(1):3085-3095. doi: 10.1080/07853890.2022.2139411. Ann Med. 2022. PMID: 36331291 Free PMC article.
-
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?Cancers (Basel). 2024 Jul 5;16(13):2466. doi: 10.3390/cancers16132466. Cancers (Basel). 2024. PMID: 39001528 Free PMC article. Review.
References
-
- Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol 2004; 22: 3608–3617. - PubMed
-
- Tabouret E, Chinot O, Metellus P, et al. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 2012; 32: 4655–4662. - PubMed
-
- Heitz F, Harter P, Lueck HJ, et al. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. Eur J Cancer 2009; 45: 2792–2798. - PubMed
-
- Sperduto PW, Kased N, Roberge D, et al. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol 2013; 112: 467–472. - PubMed
-
- Cagney DN, Lamba N, Montoya S, et al. Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases. Breast Cancer Res Treat 2019; 176: 171–179. - PubMed
LinkOut - more resources
Full Text Sources